Outlook for Healthcare Distributors

Credit Suisse’s note Healthcare Distribution 2022 Outlook: Long Awaited Inflection Point Finally In Sight discusses trends & topics the analysts believe are likely to affect drug/medical distributors in 2022, according to Credit Suisse’s recent investor survey and their CY4Q preview & 2022 outlook for the industry & each company. (more…)